
Opinion|Videos|September 30, 2024
Patient-Centered Approach to Use of Chemotherapy in Metastatic Prostate Cancer
Author(s)Fred Saad, CQ, MD, FRCS, FCAHS
The panelist discusses how incorporating chemotherapy into combination treatments for metastatic prostate cancer presents challenges such as increased resource requirements, the need for interdisciplinary collaboration, and potential inconveniences for patients, including more frequent clinic visits and laboratory monitoring.
Advertisement
Video Content above is prompted by the following:
- What are some challenges of therapeutic combinations that include chemotherapy?
- Discuss the additional resources needed to use chemotherapy (eg, need for collaboration with a medical oncologist, access to an infusion center) and potential inconveniences for the patient (eg, additional clinic visits and laboratory monitoring).
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: December 2025
2
Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
3
The UroOnc Minute: En bloc resection vs TURBT, with Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM
4
Top 10 Urology Times bladder cancer articles of 2025
5




















